Delving into the Latest Updates on PG-018 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

PG 018, PG-018, PG018

Target

JAK1 x ROCK

Action

inhibitors

Mechanism

JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors), ROCK inhibitors(Rho-associated kinases inhibitors)

Therapeutic Areas

Immune System DiseasesUrogenital Diseases

Active Indication

Glomerulonephritis, Membranous

Inactive Indication-

Originator Organization

PrimeGenX Therapeutics Co., Ltd.

Active Organization

PrimeGenX Therapeutics Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

Isolates of Mycoplasma pneumoniae and M. salivarium could be subclassified at the strain level by inhibitors (ch‐Mcin) derived from mycoplasmal cells treated with chloroform. Sixty‐one isolates of M. pneumoniae obtained from oral cavities of patients were divided into three types by their ch‐Mcin: a definite type which completely inhibits the growth of M. fermentans PG18, an indefinite type and a no‐inhibition type. Sixty‐seven isolates of M. salivarium were also divided into similar types by their ch‐Mcin which does or does not inhibit the growth of M. salivarium Hup127. In the case of isolates of M. pneumoniae and M. salivarium belonging to the indefinite type which gave ambiguous patterns in the ch‐Mcin typing, it was demonstrated that they could be clearly typed by further testing after repeated cloning.

Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993)

[The validation of the possible use of monosugars and 6-azacytidine for the elimination of Mollicutes associated with HIV/AIDS from the human urogenital tract].

Article

Author: Aleksieieva, I V ; Skrypal', I H ; Onyshchenko, A M ; Tokovenko, I P ; Havrylko, L O ; Malynovs'ka, L P ; Panchenko, L P ; Shalamaĭ, A S

A search for the methods new in principle which should block and eliminate AIDS-associated mycoplasmas was carried out. This work was conducted in two ways: 1) inhibition of vital activity of Mycoplasma fermentans PG-18 and Acholeplasma laidlawii PG-8 by 6-azacytidine; 2) establishment of carbohydrate composition of receptors for these mycoplasmas aimed at the competitive elimination of these microorganisms from urogenital tract of a man using carbohydrates. It is established that a 50%-inhibiting concentration of 6-azacytidine was 23.4 micrograms/ml for M. fermentans PG-18 and 62.5 micrograms/ml for A. laidlawii PG-8. alpha-D-glucose and N-acetylneuramine acid are two terminal carbohydrates that can serve as receptors for M. fermentans on human mucous membranes while D-mannose and N-acetyl-D-glucosamine for A. laidlawii PG-8. alpha-D-glucose in concentration 75 mM and N-acetylneuramine acid in concentration 150 mM competitively inhibit reception of M. fermentans on mucosae, while D-mannose in concentration 150 mM and N-acetyl-D-glucosamine in concentration 75 mM are antireceptor substances for A. laidlawii.

100 Deals associated with PG-018

Login to view more data